DNA Corporation (CEO Go Kyung-hwan) announced its participation in "Smart Life Week (SLW)," held at COEX in Seoul for three days from Thursday, October 10th to Saturday, October 12th.
DNA Corporation was founded with the goal of utilizing AI-based DNA data to improve children's lives and brighten their futures. It launched "ADHD BANK" to facilitate the early detection of ADHD and provide personalized diagnosis. Its vision is to become a leader in shifting the paradigm from traditional diagnostic medicine to future-oriented preventive medicine by expanding and adding services.
DNA Corporation has proven its technological prowess and innovation by entering 12 countries with proof-of-concept (PoC) solutions and winning two consecutive Innovation Awards at CES 2023 and CES 2024.
DNA Corporation emphasized, "Despite the increasing prevalence of ADHD, there is a global shortage of doctors, especially psychiatrists, making it difficult for ADHD patients to receive diagnosis and appropriate or timely treatment." They added, "Our innovative technology, combined with clinical methods, will significantly assist doctors in diagnosing difficult cases of ADHD, particularly in young children, those with disabilities, or those with mental health conditions."
Going forward, DNA Corporation aims to primarily target Asian countries, such as Japan and China, where ADHD diagnosis rates are rising.
(Omitted)
Original text: https://kr.aving.net/news/articleView.html?idxno=1794304
DNA Corporation (CEO Go Kyung-hwan) announced its participation in "Smart Life Week (SLW)," held at COEX in Seoul for three days from Thursday, October 10th to Saturday, October 12th.
DNA Corporation was founded with the goal of utilizing AI-based DNA data to improve children's lives and brighten their futures. It launched "ADHD BANK" to facilitate the early detection of ADHD and provide personalized diagnosis. Its vision is to become a leader in shifting the paradigm from traditional diagnostic medicine to future-oriented preventive medicine by expanding and adding services.
DNA Corporation has proven its technological prowess and innovation by entering 12 countries with proof-of-concept (PoC) solutions and winning two consecutive Innovation Awards at CES 2023 and CES 2024.
DNA Corporation emphasized, "Despite the increasing prevalence of ADHD, there is a global shortage of doctors, especially psychiatrists, making it difficult for ADHD patients to receive diagnosis and appropriate or timely treatment." They added, "Our innovative technology, combined with clinical methods, will significantly assist doctors in diagnosing difficult cases of ADHD, particularly in young children, those with disabilities, or those with mental health conditions."
Going forward, DNA Corporation aims to primarily target Asian countries, such as Japan and China, where ADHD diagnosis rates are rising.
(Omitted)
Original text: https://kr.aving.net/news/articleView.html?idxno=1794304